Skip to main content

Hemodynamic Effects of Isosorbide-5-Mononitrate in Patients with Coronary Artery Disease, at Rest and Under Exercise

  • Conference paper
Mononitrates

Abstract

The long-term treatment of angina pectoris (AP) with isosorbide dinitrate (ISDN), in slow-release and rapid-release form, has become accepted practice [13, 18, 20, 21], in spite of the first-pass effect [27, 28]. The action of this organic nitrate, like that of nitroglycerin, is to decrease the tone of both venous and arterial vessels. The resulting reduction of both the preload and the afterload leads to a reduction of the left ventricular (LV) oxygen requirement [1, 9, 11, 12, 15, 22, 23, 24]. It has been shown that ISDN, as well as isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN) are to be regarded as effective vasodilating agents, although of different potency [6, 8, 10, 14, 16, 17, 30, 32, 33, 35]. The major problem in therapeutic use of ISDN is that its rate of metabolism is subject to large individual variations, so that the amount of metabolites produced and the amount of unmetab-olized substance remaining are difficult to predict. Thus, the magnitude and duration of the effect of ISDN are linked with the presence of three substances exhibiting different pharmacodynamics [3, 4, 5, 26, 27, 28, 29, 31, 34].

A part of this study with 5 patients had been published previously in Med. Welt Bd.32/Heft 14a (1981)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aborelius M, Jecerof H, Malm A, Malmberg RO (1968) Acute effect of nitroglycerin on haemodynamics of angina pectoris. Br Heart J 30:407

    Article  Google Scholar 

  2. Abrams J (1980) Nitroglycerin and long-acting nitrates. N Engl J Med 302:1234

    Article  PubMed  CAS  Google Scholar 

  3. Abshagen U, Spoerl-Radun S, Betzien G, Kaufmann B, Endele R(1981) Pharmakokinetik, Wirkung und Verträglichkeit von Isosorbiddinitrat und Isosorbid-5-Mononitrat bei gesunden Versuchspersonen. Med Welt 32:508

    PubMed  CAS  Google Scholar 

  4. Abshagen U, Spoerl-Radun S (1981) First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man. Eur J Clin Pharmacol 19:423–429

    Article  PubMed  CAS  Google Scholar 

  5. Abshagen U, Betzien G, Endele R, Kaufmann B (1981) Pharmacokinetics of intravenous and oral isosorbide-5-mononitrate. Eur J Clin Pharmacol 21:269–275

    Article  Google Scholar 

  6. Assinder DF, Chasseaud LF, Taylor T (1977) Plasma isosorbide dinitrate concentrations in human subjects after administration of standard and sustained-release formulations. J Pharm Sci 66:775

    Article  PubMed  CAS  Google Scholar 

  7. Biamino G, Oeff M, Andresen D, Lichey HJ, Prokein E, Arntz R, Leitner E v, Schroeder R (1981) Haemodynamische Effekte von Isosorbid-5-Mononitrat unter Ruhe- und Belastungsbedingungen bei Patienten mit schwerer Angina pectoris. Med Welt 32:535

    PubMed  CAS  Google Scholar 

  8. Bogaert MG, Rosseel MT (1972) Vascular effects of the dinitrate and mononitrate esters of isosorbide, isomannide and isoidide. Naunyn-Schmiedebergs Arch Pharmacol 275:339

    Article  PubMed  CAS  Google Scholar 

  9. Burggraf GW, Parker JO (1974) Left ventricular volume changes after amyl nitrite and nitroglycerin in man as measured by ultrasound. Circulation 49:136

    PubMed  CAS  Google Scholar 

  10. Chasseaud LF, Down WH, Grundy RK (1975) Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood human subjects. Eur J Clin Pharmacol 8:157

    Article  PubMed  CAS  Google Scholar 

  11. Chatterjee K, Pamley WW, Swan HJ (1973) Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation 48:684

    PubMed  CAS  Google Scholar 

  12. Cohn PE, Maddox D, Holman BL, Epstein SE (1977) Effect of sublingually administered nitroglycerin on regional myocardial blood flow in patients with coronary artery disease. Am J Cardiol 39:672

    Article  PubMed  CAS  Google Scholar 

  13. Danahy DT, Aronow WS (1977) Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use. Circulation 56:205

    PubMed  CAS  Google Scholar 

  14. Danahy DT, Burwell DT, Aronow WS, Prakash R (1977) Sustained hemodynamic and antianginal effect of high dose oral isosorbide dinitrate. Circulation 55:381

    PubMed  CAS  Google Scholar 

  15. DeMaria A, Vismara L, Auditore K, Amsterdam EA, Zellis R, Mason DT (1974) Disturbances of cardiac rhythm and conduction induced by exercise. Diagnostic, prognostic and therapeutic implications. Am J Med 57:574

    Article  Google Scholar 

  16. Dietz AJ Jr (1967) The biotransformation of isosorbide dinitrate in dogs and humans. Biochem Pharmacol 16:1447

    Article  Google Scholar 

  17. Down WH, Chasseaud LF (1978) 2. Internationales Nitrat-Symposium, Berlin 1978 — “The metabolism of isosorbide dinitrate” (Abstr). Herz 3:206

    Google Scholar 

  18. Franciosa FA, Cohn JN (1980) Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. Am J Cardiol 45:648

    Article  PubMed  CAS  Google Scholar 

  19. Isbary J, Doering W, Wauer B, Greding H, Koenig E (1981) Haemodynamische Veränderungen in Ruhe und während Belastung nach 20 mg Isosorbid-5-Mononitrat bei Patienten mit koronarer Herzerkrankung. Med Welt 32:530

    PubMed  CAS  Google Scholar 

  20. Kaltenbach M, Becker HJ (1979) Nitrate in der Therapie der koronaren Herzkrankheit. Dtsch Med Wochenschr 104:1723

    Article  PubMed  CAS  Google Scholar 

  21. Lee G, Mason DT, DeMaria AN (1978) Effects of long-term oral administration of isosorbide dinitrate on the antianginal response to nitroglycerin. Am J Cardiol 41:82

    Article  PubMed  CAS  Google Scholar 

  22. Mason DT, Braunwald E (1965) The effects of nitroglycerin and amyl nitrite on arteriolar and venous tone in the human forearm. Circulation 32:755

    PubMed  CAS  Google Scholar 

  23. Mason DT, Zelis R, Amsterdam EA (1971) Actions of the nitrites on the peripheral circulation and myocardial oxygen consumption: significance in the relief of angina pectoris. Chest 59:296

    Article  PubMed  CAS  Google Scholar 

  24. Mason DT, Awan NA, DeMaria A, Lee G, Amsterdam EA (1980) Cardiocirculatory effects of nitrates in the treatment of clinical congestive heart failure. In: Rudolph W, Schrey A (eds) Nitrate II. Urban und Schwarzenberg, p206

    Google Scholar 

  25. Mehmel HC, Ruffmann K, Schwarz F, Manthey J, Kuebler W (1981) Die Wirkung von Isosor-bid-5-Mononitrat (IS-5-MN) auf die linksventrikuläre Haemodynamik. Med Welt 32:527

    PubMed  CAS  Google Scholar 

  26. Michel D (1970) Der Einfluß von Metaboliten des Isosorbid-Dinitrats auf das Belastungs-EKG bei Koronarinsuffizienz. Herz-Kreisl 8:444

    Google Scholar 

  27. Needleman Ph, Lang S, Johnson E (1972) Organic nitrates: Relationship between biotransformation and rational angina pectoris therapy. J Pharmacol Exp Ther 181:489

    PubMed  CAS  Google Scholar 

  28. Needleman Ph (1976) Organic nitrate metabolism1,2. Ann Rev Pharmacol 16:81

    Article  CAS  Google Scholar 

  29. Orr J, Klein G, Shaar SF (1978) Plasma concentrations of isosorbide dinitrate and two major metabolites following oral administration of two formulations of isosorbide dinitrate tablets. Can J Pharm Sci 2:45

    Google Scholar 

  30. Seidel F, Michel D (1980) “3rd Int. Symp. Nitrates, Monte-Carlo”. Abstract 13

    Google Scholar 

  31. Shane SJ, Iazzetta JJ, Chisholm AW, Berka JF, Leung D (1978) Plasma concentrations of isosorbide dinitrate and its metabolites after chronic high oral dosage in man. Br J Clin Pharmacol 6:37

    PubMed  CAS  Google Scholar 

  32. Sisenwine SF, Ruelius HW (1971) Plasma concentrations and urinary excretion of isosorbide dinitrate and its metabolites in the dog. J Pharmacol Exp Ther 176:296

    PubMed  CAS  Google Scholar 

  33. Spoerl-Radun S, Betzien G, Kaufmann B, Liede V, Abshagen U (1980) Effects and pharmacokinetics of isosorbide dinitrate in normal man. Eur J Clin Pharmacol 18:237

    Article  CAS  Google Scholar 

  34. Stauch M, Grewe N (1979) Die Wirkung von Isosorbiddinitrat, Isosorbid-2- und -5-Mononitrat auf das Belastungs-EKG und auf die Haemodynamik während Vorhofstimulation bei Patienten mit Angina pectoris. Z Kardiol 68:687

    PubMed  CAS  Google Scholar 

  35. Wendt RL (1972) Systemic and coronary vascular effects of the 2- and the 5-mononitrate esters of isosorbide. J Pharmacol Exp Ther 180:732

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Biamino, G. et al. (1985). Hemodynamic Effects of Isosorbide-5-Mononitrate in Patients with Coronary Artery Disease, at Rest and Under Exercise. In: Cohn, J.N., Rittinghausen, R. (eds) Mononitrates. International Boehringer Mannheim Symposia. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70234-1_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70234-1_33

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-15107-4

  • Online ISBN: 978-3-642-70234-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics